Molecular pathogenesis of astrocytoma and glioblastoma multiforme

Acta Neurochirurgica

Volumn 139, Issue 7, 1997, Pages 589-599

  Van De Kelft, E ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Brain neoplasm; Cell cycle; Molecular biology; Oncogene; Tumour suppressor gene; Tumourigenesis

Indexed keywords

ASTROCYTOMA; BRAIN TUMOR; CARCINOGENESIS; CELL CYCLE; CHROMOSOME; GENE AMPLIFICATION; GLIOBLASTOMA; HUMAN; MOLECULAR BIOLOGY; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

ASTROCYTOMA; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS;

EID: 0030802366     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01411992     Document Type: Review

References (88)

1. Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin J-P, Järvinen H, Powell S, Hamilton SR, Petersen GM, Kinzler KW, Vogelstein B, de la Chapelle A (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260: 812-816
2. Barker D, Wright E, Nguyen K, Cannon L, Fain P, Goldgar D, Bishop DT, Carey J, Batry B, Kivlin J, Willard H, Waye JS, Greig G, Leinwand L, Nakamura Y, O'Connell P, Leppert M, Lalouel J-M, White R, Skolnick M (1987) Gene for von Recklinghausen neurofibromatosis is on the pericentromeric region of chromosome 17. Science 236: 1100-1102
3. Bigner SH, Burger PC, Wong AJ, Werner MH, Hamilton SR, Muhlbaier LH, Vogelstein B, Bigner DD (1988) Gene amplification in malignant human gliomas: clinical and histopathologic aspects. J Neuropathol Exp Neurol 47: 191-205
4. Bigner SH, Mark J, Burger PC, et al (1988) Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 88: 405-411
5. Bigner SH, Wong AJ, Mark J, et al (1987) Relationship between gene amplification and chromosomal deviations in malignant human gliomas. Cancer Genet Cytogenet 29: 165-170
6. Bishop JM (1987) The molecular genetics of cancer. Science 235: 305-311
7. Bögler O, Su Huang HJ, Kleihues P, Cavanee W (1995) The p53 gene and its role in human brain tumours. Glia 15: 308-327
8. Chen P-L, Chen Y, Bookstein R, Lee W-H (1990) Genetic mechanisms of tumour suppression by the human p53 gene. Science 250: 1576-1580
9. Chung RY, Whaley J, Kley N (1991) p53 mutation and chromosome 17p deletion in human astrocytomas. Genes Chrom Cancer 3: 323-331
10. Collins VP (1995) Gene amplification in human gliomas. Glia 15: 289-296
11. Costello JF, Berger MS, Huang HS, Cavanee WK (1996) Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res 56 (10): 2405-2010
12. Dams E, Van de Kelft EJZ, Martin J-J, Verlooy J, Willems P (1995) Instability of microsatellites in human gliomas. Cancer Res 55: 1547-1549
13. Danova M, Riccardi A, Gaetani P, et al (1988) Cell kinetics of human brain tumours: in vivo study with bromodeoxyuridine and flow cytometry. Eur J Cancer Clin Oncol 24: 873-880
14. Daub DM. Tada M, Ishii N, Estreicher A, Iggo R, Janzer R, de Tribolet N, Diserens A-C, Van Meir EG (1996) Mutant p53 and the prognosis of low-grade astrocytoma. J Neurooncol 30 (2): 129
15. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P (1988) Grading of astrocytomas: a simple and reproducible method. Cancer 62: 2152-2165
16. Diedrich U, Lucius J, Baron E, Behnke J, Pabst B, Zoll B (1995) Distribution of epidermal growth factor receptor gen amplification in brain tumours and correlation to prognosis. J Neurol 242: 683-688
17. Diedrich U, Lucius J, Bittermann H-J, Schlösser M, Ecker B, Behnke J, Pabst B (1995) Loss of alleles in brain tumours: distribution and correlations with clinical course. J Neurol 242: 707-711
18. Dirven CM, Tuerlings J, Molenaar LM, Go KG, Louis DN (1995) GBM in four siblings: a cytogenetic and molecular genetic study. J Neurooncol 24 (3): 251-258
19. Duesberg PH (1987) Cancer genes: rare combinants instead of activated oncogenes (review). Proc Natl Acad Sci USA 84: 2117-2134
20. El-Azouzi M, Chung R, Farmer GE, Martuzza RL, Black PMcL, Rouleau GA, Hettlich C, Hedley Whyte ET, Zervas NT, Panagopoulos K, Nakamura Y, Gusella JF, Seizinger BR (1989) Loss of distinct regions on the short arm of chromosome 17 associated with tumourigenesis of human astrocytomas. Proc Natl Acad Sci USA 86: 7186-7190
21. Feuerstein BG, Mohapatra G (1995) Molecular cytogenetic quantitation of gains and losses of genetic material from human gliomas. J Neurooncol 24: 47-55
22. Fischer U, Müller H-W, Sattler H-P, Keiden K, Zang KD, Meese E (1995) Amplification of the MET gene in glioma. Genes Chrom Cancer 12: 63-65
23. Frankel R, Bayonna W, Koslow M, Newcomb E (1992) p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res 52: 1427-1433
24. Frebourg T, Friend S (1992) Cancer risks from germline p53 mutations. J Clin Invest 90: 1637-1641
25. Friend SJ, Bernard R, Rogelj S, Weinberg RA, Rapapport JM, Albert DM, Dryja TP (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643-646
26. Gomez-Manzano C, Fueyo J, Kyritsis AP, Steck PA, Roth JA, McDonnell TJ, Steck KD, Levin VA, Yung WK (1996) Adenovirus mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res 56 (4): 694-699
27. Goustin AS, Leof EB, Shipley GD, Moses HL (1986) Cancer Res 46: 1015-1029
28. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations of the p53 tumour-suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4655-4678
29. Hansen MF, Cavanee WK (1987) Genetics of cancer predisposition. Cancer Res 47: 5518-5527
30. Hecht B, Turc-Carel C, Chatel M, Grellier P, Gioanni J, Attias R, Gaudray P, Hecht F (1995) Cytogenetics of malignant gliomas. Cancer Genet Cytogenet 84: 1-8
31. Heiskanen M, Peltonen L, Palotie A (1996) Visual mapping by high resolution FISH. TIG 12 (10: 379-382
32. Heldin CH, Johnsson A, Wennergren S, Wernstedt C, Betzholtz C, Westermark B (1986) A human osteosarcome cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains. Nature 319: 511-514
33. Helseth E, Unsgaard G, Dalen A, Fure H, Skandsen T, Odegaard A, Vik R (1988) Amplification of the epidermal growth factor receptor gene in biopsy specimens from human intracranial tumours. Br J Neurosurg 2: 217-255
34. Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu H-J, Benedict WF, Louis DN (1994) The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 36: 714-721
35. Hinds PW, Finlay CA, Quartin RS, Baker SJ, Fearon ER, Vogelstein B, Levine AJ (1990) Mutant p53-DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes. Cell Growth Differ 1: 571-580
36. Iggo R, Gatter K, Bartek J, Lane D, Harris AL (1990) Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335: 675-679
37. James CD, Carlbom E, Nordenskjold M, Collins VP, Cavenee WK (1989) Mitotic recombination of chromosome 17 in astrocytomas. Proc Natl Acad Sci USA 86: 2858-2862
38. James CG, Carlbom E, Dumanski JP, Hansen M, Nordenskjold M, Collins VP, Cavenee WK (1988) Clonal genomic alterations in glioma malignant stages. Cancer Res 48: 5546-555
39. Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O'Brian SJ, Wong AJ (1987) Science 236: 70-73
40. Lleihues P, Burger PC, Scheithauer BW (1993) Histological typing of tumours of the central nervous system. Springer, Berlin Heidelberg New York Tokyo
41. Klein G (1988) Oncogenes and tumour suppressor genes. Rev Oncol 1: 427-437
42. Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823
43. Levine AJ, Momand J, Finlay C (1991) The p53 tumour suppressor gene. Nature 351: 453-456
44. Li FP, Fraumeni JF, Mulvihill JJ, Blattner WA, Dreyfus WA, Tucker MG, Miller RW (1988) A cancer family syndrome in 24 kindreds. Cancer Res 48: 5358-5362
45. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313: 144-147
46. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J (1985) Amplification, enhanced expression and possible rearrangement of the EGF receptor gene in primary human brain tumours of glial origin. Nature 313: 144-147
47. Malden LT, Novak U, Kaye A, Burgess AW (1988) Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme. Cancer Res 48: 2711-2714
48. McDonald JD, Dohrman GJ (1988) Molecular biology of brain tumours. Neurosurgery 23(5): 537-544
49. Menon AG, Anderson KM, Riccardi VM, Chung RY, Whaley JM, Yandell DW, Farmer GE, Freiman RN, Lee JK, Li FP, Barker DF, Ledbetter DH, Kleider A, Martuza RL, Gusella JF, Seizinger BR (1990) Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Retklinghausen neurofibromatosis. Proc Natl Acad Sci USA 87: 5435-5439
50. Metzger A, Sheffield V, Duyk G, Danheshvar L, Edwards M, Cogen P (1991) Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma. Proc Natl Acad Sci USA 88: 7825-7829
51. Mineta T, Fukuyama K, Shiraishi T, et al (1991) The expression and structure of p53 Gene products in cultured glioma cells. In: Tabuchi K (ed) Biological aspects of human brain tumours. Springer, Berlin Heidelberg New York Tokyo
52. Momand J, Zambetti GP, Olson DC, George DL, Levine AJ (1992) The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated trans-activation. Cell 69: 1237-1245
53. Morrison RS, de Villis J (1981) Growth of purified astrocytes in a chemically defined medium. Proc Natl Acad Sci USA 78: 7205-7209
54. Morrison RS, Gross JL, Herbin WF (1990) Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. Cancer Res 50: 2524-2529
55. Murphree AL, Benedict WF (1984) Retinoblastoma: clues to human oncogenesis. Science 223: 1028-1033
56. Nister M, Libermann TA, Betzholtz C (1988) Expression of messanger RNAs for PDGF and TGF and their receptors in human malignant gliomas. Cancer Res 48: 3908-3910
57. Olopade O, Bohlander S, Pomykala H, Maltepe E, Van Melle E, Le Beau M, Diaz M (1992) Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia. Genomics 14: 437-443
58. Penar PL, Khoshyomn S, Bhushan A, Tritton TR (1997) Inhibition of epidermal growth factor receptor-associated tyrosine kinase blocks glioblastoma invasion in the brain. Neurosurgery 40: 141-151
59. Rasheed BKA, McLendon RE, Friedman HS, Friedman AH, Fuchs HE, Bigner DD, Bigner SH (1995) Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene 10: 2243-2246
60. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53: 2736-2739
61. Rev JA, Bello MJ, de Campos JM, Kusak ME, Ramos C, Benitez J (1987) Chromosomal patterns in human malignant astrocytomas. Cancer Genet Cytogenet 29 (2): 201-223 CaGCG 29: 223
62. Rev JA, Bello MJ, de Campos JM, Kusak ME, Ramos C, Benitez J (1987) Chromosomal patterns in human malignant astrocytomas. Cancer Genet Cytogenet 29 (2): 201-223 CaGCG 29: 223
63. Ritland SR, Vinod G, Jenkins RB (1995) Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chrom Cancer 12: 277-287
64. Rivera VM, Greenberg ME (1990) Growth factor induced gene-expression: the ups and downs of c-fos regulation. New Biol 2: 751-758
65. Samuels V, Barrett JM, Bockman S, et al (1989) Immunohistochemical study of transforming growth factor expression in benign and malignant gliomas. Am J Pathol 134: 895-902
66. Sauter G, Maeda T, Waldman FM, Davis RL, Feuerstein BG (1996) Patterns of epidermal growth factor receptor amplification in malignant gliomas. Am J Pathol 148(4): 1047-1053
67. Schlessinger J (1988) The epidermal growth factor receptor as a multifunctional allosteric protein. Biochemistry 27: 3119-3123
68. Schmidt EE, Ichimura K, Reifenberger G, Collins VP (1994) CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 54: 6321-6324
69. Sidransky D, Mikkelsen T, Schwegheimer K, Rosenblum M, Cavanee W, Vogelstein B (1992) Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355: 846-847
70. Steck PA, Ligon AH, Cheong P, Yung WKA, Pershouse MA (1995) Two tumour suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chrom Cancer 12: 255-261
71. Stehelin D, Varmus HE, Bishop JM (1976) DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260: 170-173
72. Tsuzuki T, Tsunoda S, Sakaki T, Konishi N, Hiasa Y, Nakamura M (1996) Alterations of retinoblastoma, p53, p16 (CDKN2), and p15 genes in human astrocytomas. Cancer 78 (2): 287-293
73. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN (1996) CDKN2/P16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 56 (1): 150-153
74. Ullrich A, Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212
75. Van de Kelft E, De Boulle K, Willems P, Martin JJ, Selosse P, Van de Auwera B (1992) Loss of constitutional heterozygosity in human astrocytomas. Acta Neurochir (Wien) 117: 172-177
76. Van de Kelft EJZ, De Boulle K, Martin JJ, Verlooy J, Willems P (1997) Deletion of the p16/CDKN2 tumor suppressor gene in primary human gliomas. Personal data
77. Van de Kelft EJZ, Verlooy J (1994) Instability of short tandem repeats in human gliomas. J Neurosurg Sci 38: 203-208
78. Van Meir EG, Polverini PJ, Chazin VR, Huang H-JS, de Tribolet N, Cavanee WK (1994) Release of an inhibitor of angiogenesis upon induction of wild-type p53 expression in glioblastoma cells. Nature Genet 8: 171-176
79. Virchow R (1963) Die krankhaften Geschwülste. Hirschwald, Berlin
80. Vogelstein B, Kinzler K (1992) p53 function and dysfunction. Cell 70: 523-526
81. von Deimling AHR, Louis DN, Wiestler OD (1995) Molecular pathways in the formation of gliomas. Glia 15: 328-338
82. von Deimling AHR, Louis DN, von Ammon K, Petersen I, Hoell T, Chung R, Martuza R, Schoenfeld DA, Yasargil MG, Wiestler O, Seizinger BR (1992) Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human GBM. J Neurosurg 77: 295-301
83. von Deimling AHR, Eibl R, Ohgaki H, Louis D, von Ammon K, Petersen I, Kleihues P, Chung R, Wiestler O, Seizinger B (1992) p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res 52: 2987-2990
84. Westphal M, Herrmann H-D (1989) Growth factor biology and oncogene activation in human gliomas and their implications for specific therapeutic concepts. Neurosurgery 25: 681-694
85. Wong AJ, Bigner SH, Kinzler KW, Hamilton SR, Vogelstein B (1987) Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84: 6899-6903
86. Wullich B, Sattler HP, Fischer U, Meese E (1994) Two independent amplification events on chromosome 7 in glioma: amplification of the EGFR gene and amplification of the oncogene MET. Anticancer Res 14: 577-579
87. Yamazaki H, Fukui Y, Ueyama Y, Tamaoki N, Kawamoto T, Taniguchi S, Shibuya M (1988) Mol Cell Biol 8: 1816-1820
88. Yewdell JW, Gannon JV, Lane DP (1986) Monoclonal antibody analysis of p53 expression in normal and transformed cells. J Virol 59: 444-452